System and method for structured narcotic cessation using ingestion modality reduction and dosage tapering framework

Abstract

The invention provides a structured framework and associated technology system for narcotic cessation through controlled reduction in ingestion method intensity and dosage tapering. Specifically, it defines a therapeutic protocol involving transitioning patients down an ordered ingestion-intensity ladder—from highly reinforcing methods such as injection, through intermediate modalities such as insufflation and oral ingestion, to minimally reinforcing methods like transdermal patches—while concurrently reducing drug dosage. Implemented through an integrated technological platform comprising software and optional hardware components, the system dynamically guides patients, tracks adherence, provides clinician oversight, and integrates behavioral reinforcement strategies such as randomized rewards and gamified progress tracking. This dual-axis approach to narcotic cessation significantly addresses the limitations of existing treatment methodologies by personalizing intervention, minimizing withdrawal symptoms, and enhancing patient compliance and engagement. The invention is particularly applicable in clinical treatment programs addressing opioid dependency and other substance use disorders.

Dependencies are inferred from the claim text.